Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Feb;35(2):107753.
doi: 10.1016/j.jdiacomp.2020.107753. Epub 2020 Oct 9.

Diabetes status modifies the efficacy of home-based kidney care for Zuni Indians in a randomized controlled trial

V Shane Pankratz  1 , E Eunice Choi  1 , Fares Qeadan  2 , Donica Ghahate  1 , Jeanette Bobelu  1 , Robert G Nelson  3 , Thomas Faber  4 , Vallabh O Shah  5
Affiliations
Randomized Controlled Trial

Diabetes status modifies the efficacy of home-based kidney care for Zuni Indians in a randomized controlled trial

V Shane Pankratz et al. J Diabetes Complications. 2021 Feb.

Abstract

Background: Home-Based Kidney Care (HBKC) is a pragmatic treatment approach that addresses patient preferences and cultural barriers to healthcare. We previously reported the results of a clinical trial of HBKC vs. usual care in a cohort of Zuni Indians in New Mexico. This study investigated the potential for differential efficacy of HBKC vs. usual care according to type 2 diabetes (T2DM) status.

Methods: We analyzed the data from all individuals who participated in a randomized clinical trial that compared HBKC to usual care among patients with CKD, and assessed whether the effect of the HBKC intervention affected the subset of patients with T2DM differently than those individuals without T2DM. We used linear regression models to estimate the effect of HBKC on improvement in Patient Activation Measure (PAM) total scores within the groups of participants defined by T2DM status, and to compare the effects between these two groups. We used generalized estimating equations (GEE) to account for household clustering.

Results: The original study enrolled 63 participants into the HBKC group, and 62 into the usual care. Ninety-eight of these individuals completed the 12-month intervention, 50 in the HBKC group and 48 in the usual care group. The present study compared the intervention effect in the 56 participants with T2DM (24 participants in the HBKC group and 32 in usual care) to the intervention effect in the 42 participants without T2DM (26 participants in the HBKC group and 16 in usual care). Those with T2DM who received the HBKC intervention experienced an average increase in PAM total scores of 16.0 points (95% Confidence Interval: 8.8-23.1) more than those with T2DM who were in the usual care group. For those without T2DM, the intervention had essentially no effect, with those who received the HBKC intervention having an average PAM total scores that was 1.4 points (95% C.I.: -12.4 to 9.6) lower than those who received usual care. There was a significantly different HBKC treatment effect by T2DM status (p = 0.02).

Conclusion: This secondary analysis suggests that the effectiveness of this HBKC intervention on increasing patient activation is most notable among those CKD patients who also have T2DM.

Keywords: Chronic kidney disease; Diabetes; Patient activation measure; Randomized controlled trial; Zuni Indians.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest None of the authors listed has conflict of interest.

Figures

Figure 1.
Figure 1.
Data Flowchart
Figure 2:
Figure 2:
(left panel): PAM score at 12 months versus at baseline for participants with diabetes (left panel) and for participants without diabetes (right panel. A reference line of no change over time is shown, along with different plotting symbols for those in the HMKC (Treatment) and usual care (Control) groups.
See this image and copyright information in PMC

References

    1. Koye DN, Magliano DJ, Nelson RG, Pavkov ME. The Global Epidemiology of Diabetes and Kidney Disease. Adv Chronic Kidney Dis. 2018;25(2):121–32. - PMC - PubMed
    1. Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, Weiss NS, et al. Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988–2014. JAMA. 2016. August 9;316(6):602–10. - PMC - PubMed
    1. Crews DC, Bello AK, Saadi G, World Kidney Day Steering Committee. Burden, Access, and Disparities in Kidney Disease. Am J Hypertens. 2019. 16;32(4):433–9. - PubMed
    1. Shah VO, Ghahate DM, Bobelu J, Sandy P, Newman S, Helitzer DL, et al. Identifying barriers to healthcare to reduce health disparity in Zuni Indians using focus group conducted by community health workers. Clin Transl Sci. 2014. February;7(1):6–11. - PMC - PubMed
    1. Whitbeck LB, Adams GW, Hoyt DR, Chen X. Conceptualizing and measuring historical trauma among American Indian people. Am J Community Psychol. 2004. June;33(3–4):119–30. - PubMed

Publication types